CD36 and posterior cortical atrophy: In addition, a cell-counting study revealed that inhibiting CD36 alone had little effect on cell proliferation, while the combination of anti-CD36 and enzalutamide resulted in fewer PCa cells compared to enzalutamide alone (p < 0.05; Figure 6b).